Your browser doesn't support javascript.
loading
Master Protocols and Adaptive Trial Designs to Develop Tumor-Agnostic Drugs for Children: Essential Tools in the Era of the Research to Accelerate Cures and Equity Act.
Arfè, Andrea; Silverman, Lewis B; Bourgeois, Florence.
Afiliação
  • Arfè A; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts.
  • Silverman LB; Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts.
  • Bourgeois F; Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program, Boston Children's Hospital, Boston, Massachusetts.
JAMA Oncol ; 7(9): 1281-1282, 2021 09 01.
Article em En | MEDLINE | ID: mdl-34110376
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article